Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000214090 | SCV000270778 | likely benign | not specified | 2016-01-26 | criteria provided, single submitter | clinical testing | p.Thr57Thr in exon 2 of RAF1: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 4/66734 European chr omosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.o rg; dbSNP rs751571550). |
Gene |
RCV001711994 | SCV001942661 | likely benign | not provided | 2021-02-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002517493 | SCV003449541 | likely benign | RASopathy | 2023-12-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004020601 | SCV004936056 | likely benign | Cardiovascular phenotype | 2021-02-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |